Ensysce Biosciences Financials
ENSCWDelisted Stock | USD 0.01 0.0008 8.16% |
Ensysce |
Understanding current and past Ensysce Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ensysce Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Ensysce Biosciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ensysce Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ensysce Biosciences. Check Ensysce Biosciences' Beneish M Score to see the likelihood of Ensysce Biosciences' management manipulating its earnings.
Ensysce Biosciences Stock Summary
Ensysce Biosciences competes with Ensysce Biosciences. Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. Ensysce Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange.Specialization | Healthcare, Biotechnology |
Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
CUSIP | 52539T115 293602116 |
Location | California; U.S.A |
Business Address | 7946 Ivanhoe Avenue, |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | ensysce.com |
Phone | 858 263 4196 |
Currency | USD - US Dollar |
Ensysce Biosciences Key Financial Ratios
There are many critical financial ratios that Ensysce Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ensysce Biosciences reports annually and quarterly.Ensysce Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ensysce Biosciences's current stock value. Our valuation model uses many indicators to compare Ensysce Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ensysce Biosciences competition to find correlations between indicators driving Ensysce Biosciences's intrinsic value. More Info.Ensysce Biosciences is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ensysce Biosciences' earnings, one of the primary drivers of an investment's value.Ensysce Biosciences Market Pulse
Quote | 0.009 |
Change(%) | 8.16 |
Change | 0.0008 |
Open | 0.0098 |
Low | 0.007 |
High | 0.0098 |
Volume | 0 |
Exchange | PINK |
Ensysce Biosciences November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ensysce Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ensysce Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ensysce Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Ensysce Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ensysce Biosciences's daily price indicators and compare them against related drivers.
Downside Deviation | 31.69 | |||
Information Ratio | 0.1268 | |||
Maximum Drawdown | 555.68 | |||
Value At Risk | (47.33) | |||
Potential Upside | 85.33 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamental Analysis View fundamental data based on most recent published financial statements |